Literature DB >> 28286904

Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis.

Orit Barrett1,2, Ella Abramovich1, Jacob Dreiher3, Victor Novack1,2, Mahmoud Abu-Shakra4,5.   

Abstract

Severe infections and sepsis are common among patients with rheumatoid arthritis (RA) and are associated with increased morbidity and mortality risks. To determine whether RA is an independent risk factor for short- and long-term mortality in patients admitted to an Intensive Care Unit (ICU) with sepsis. A retrospective age- and sex-matched cohort study, based on data of the SEPSIS-ISR Registry, an ongoing study that collects data on all patients admitted with the diagnosis of sepsis to the ICUs of 7 large hospitals during the period 2002-2012. The primary outcomes of the study were the 30-day and 3-years survival rates. A total of 124 RA patients and 248 non-RA patients (mean age 71 years; 64.5% female) were included. Primary site of infection as well as pathogens distributions were similar between the two groups. Severe sepsis and septic shock were diagnosed in 92% vs. 84% (p = 0.03) and 50% versus 39% (p = 0.06) of the RA patients and non-RA, respectively. 30-day survival rates were similar between groups, whereas 3-year survival rate in 30-day survivors was significantly lower among RA patients (34.9%) compared to non-RA patients (55.7%) (p = 0.01). In multivariate Cox proportional hazards regression, RA was found to be a significant independent risk factor for 3-year mortality in 30-day survivors (hazard ratio 1.63 95% confidence interval 1.03-1.63; p = 0.04). RA is an independent risk factor for 3-year mortality, but not short-term mortality following ICU admission with sepsis.

Entities:  

Keywords:  Mortality infections; Rheumatoid arthritis; Sepsis

Mesh:

Year:  2017        PMID: 28286904     DOI: 10.1007/s00296-017-3694-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Sepsis in European intensive care units: results of the SOAP study.

Authors:  Jean-Louis Vincent; Yasser Sakr; Charles L Sprung; V Marco Ranieri; Konrad Reinhart; Herwig Gerlach; Rui Moreno; Jean Carlet; Jean-Roger Le Gall; Didier Payen
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

4.  National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study.

Authors:  Elaine Thomas; Deborah P M Symmons; David H Brewster; Roger J Black; Gary J Macfarlane
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

5.  Rheumatoid arthritis disease activity and disability affect the risk of serious infection events in RADIUS 1.

Authors:  Arthur Weaver; Orrin Troum; Michele Hooper; Andrew S Koenig; Sandeep Chaudhari; Jingyuan Feng; Deborah Wenkert
Journal:  J Rheumatol       Date:  2013-06-15       Impact factor: 4.666

6.  Predictors of long-term mortality after severe sepsis in the elderly.

Authors:  Allyson C Lemay; Antonio Anzueto; Marcos I Restrepo; Eric M Mortensen
Journal:  Am J Med Sci       Date:  2014-04       Impact factor: 2.378

7.  Death rates and causes of death in patients with rheumatoid arthritis: a population-based study.

Authors:  S Sihvonen; M Korpela; P Laippala; J Mustonen; A Pasternack
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

8.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Authors:  C Brun-Buisson; F Doyon; J Carlet; P Dellamonica; F Gouin; A Lepoutre; J C Mercier; G Offenstadt; B Régnier
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

9.  Long-term mortality after community-acquired sepsis: a longitudinal population-based cohort study.

Authors:  Henry E Wang; Jeff M Szychowski; Russell Griffin; Monika M Safford; Nathan I Shapiro; George Howard
Journal:  BMJ Open       Date:  2014-01-17       Impact factor: 2.692

10.  Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China.

Authors:  Jianfang Zhou; Chuanyun Qian; Mingyan Zhao; Xiangyou Yu; Yan Kang; Xiaochun Ma; Yuhang Ai; Yuan Xu; Dexin Liu; Youzhong An; Dawei Wu; Renhua Sun; Shusheng Li; Zhenjie Hu; Xiangyuan Cao; Fachun Zhou; Li Jiang; Jiandong Lin; Enqiang Mao; Tiehe Qin; Zhenyang He; Lihua Zhou; Bin Du
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more
  5 in total

1.  Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study.

Authors:  Yael Haviv-Yadid; Yulia Segal; Amir Dagan; Kassem Sharif; Nicola Luigi Bragazzi; Abdulla Watad; Howard Amital; Yehuda Shoenfeld; Ora Shovman
Journal:  Clin Rheumatol       Date:  2019-06-26       Impact factor: 2.980

2.  Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran.

Authors:  Mojgan Arjmand; Reza Shahriarirad; Saeedeh Shenavandeh; Mohammad Javad Fallahi
Journal:  Clin Rheumatol       Date:  2022-08-15       Impact factor: 3.650

3.  Mortality of Sepsis in Patients With Rheumatoid Arthritis: A Single-Center Retrospective Analysis and Comparison With a Control Group.

Authors:  Marco Krasselt; Christoph Baerwald; Sirak Petros; Olga Seifert
Journal:  J Intensive Care Med       Date:  2020-04-06       Impact factor: 3.510

4.  Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients.

Authors:  Akram Mohammed; Yan Cui; Valeria R Mas; Rishikesan Kamaleswaran
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

5.  COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence.

Authors:  Vincenzo Venerito; Giuseppe Lopalco; Florenzo Iannone
Journal:  Rheumatol Int       Date:  2020-03-30       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.